Navigation Links
Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop

the results indicated by these forward-looking statements, including: adverse results in its drug discovery and clinical development programs; failure to obtain patent protection for its discoveries; commercial limitations imposed by patents owned or controlled by third parties; the Company's dependence upon strategic alliance partners to develop and commercialize products and services based on its work; difficulties or delays in obtaining regulatory approvals to market products and services resulting from its development efforts; product withdrawals; competitive factors; difficulties or delays in manufacturing the Company's products; government and third-party reimbursement rates; the commercial success of VELCADE and INTEGRILIN(R) (eptifibatide) Injection; achieving revenue consistent with internal forecasts; and the requirement for substantial funding to conduct research and development and to expand commercialization activities. For a further list and description of the risks and uncertainties the Company faces, see the reports it has filed with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Editors' Note: This press release is also available under the Media section of the Company's website at: www.millennium.com. All session times listed are Eastern European Daylight Time.

CONTACT: Jennifer Snyder (media), +1-617-444-1439, or Kyle Kuvalanka(investors), +1-857-498-0818

Web site: http://www.millennium.com/

Company News On-Call: http://www.prnewswire.com/comp/114562.html /

Ticker Symbol: (NASDAQ-NMS:MLNM)

Terms and conditions of use apply
Copyright ©
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
5. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
6. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
10. Aquavan (Fospropofol Disodium) Injection Data Presented at Digestive Disease Week 2007
11. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
Post Your Comments:
(Date:9/30/2014)... YORK , Sept. 30, 2014 The ... stage. Both established medical-device providers as well as new ... European region, while simultaneously looking at ways to reduce ... sector. Using distributors is one of the effective means ... medical devices distribution market in Eastern European and provides ...
(Date:9/30/2014)... NEW YORK , Sept. 30, 2014 /PRNewswire/ ... collaboration, according to a new report from Kalorama ... 100 deals had occurred in proteomics in the ... and IPOs, to agreements between private proteomic companies ... biotech companies with novel proteomics innovator companies.  Kalorama ...
(Date:9/30/2014)... , Sept. 30, 2014 Passport Health, ... America , has launched FluFree.com, a website designed ... vaccinations. For 20 years, Passport Health has ... the flu. The launch of FluFree.com is designed to ... and the number of people who actually chose to ...
Breaking Medicine Technology:Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 3Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 2Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 3
... One of China,s Most Influential Companies -- Announces Repurchase ... 20 American Dairy, Inc. (NYSE Arca: ADY), one ... formula, milk powder and soybean, rice and walnut products ... continues to increase its production output and customer support ...
... HOLLYWOOD, Fla., Jan. 19 A new approach to ... less down time, lower costs and less risk overall, ... at the 21st annual International Symposium on Endovascular Therapy ... angioplasty over bypass surgery to open their blocked arteries. ...
Cached Medicine Technology:American Dairy Provides Business Update 2American Dairy Provides Business Update 3American Dairy Provides Business Update 4American Dairy Provides Business Update 5American Dairy Provides Business Update 6Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries 2
(Date:9/30/2014)... no genetic evidence that high levels of vitamin D ... Some previous research had suggested that elevated levels ... diabetes, raising the possibility of a link between vitamin ... this study, British researchers investigated the association between diabetes ... control blood levels of vitamin D. They found no ...
(Date:9/30/2014)... 2014 (HealthDay News) -- Children conceived either less than one ... a sibling could be at increased risk for autism, a ... and an outside expert agree that the research can,t prove ... "Most importantly, it is important that parents understand that the ... are close together or far apart," said outside expert Dr. ...
(Date:9/30/2014)... to cut climate-changing carbon emissions will reduce other ... benefits, according to a new study released today. ... options included in the final Clean Power Plan, ... premature deaths and hospitalizations, and hundreds of heart ... the new study, Health Co-benefits of Carbon Standards ...
(Date:9/30/2014)... By Alan Mozes ... 2014 (HealthDay News) -- Colon cancer patients who are ... slightly higher risk for developing a second weight-related cancer, ... to the risk of colon cancer recurrence, only the ... , "We found that colorectal cancer survivors who reported ...
(Date:9/30/2014)... lung cancer, breast cancer is the leading cause of ... Society. That,s why so many medical professionals encourage women ... at best: only a minority of suspicious mammograms actually ... lots of needless worry for women and their familiesnot ... tests, including ultrasounds and biopsies. , Recently, a ...
Breaking Medicine News(10 mins):Health News:Gene Study Finds No Proof Vitamin D Guards Against Type 2 Diabetes 2Health News:Spacing Between Sibling Births Tied to Autism Risk in Study 2Health News:Power plant standards could save thousands of US lives every year 2Health News:Power plant standards could save thousands of US lives every year 3Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 2Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 3Health News:'Virtual breast' could improve cancer detection 2
... BOZEMAN, Mont. -- West Nile virus is apparently here to ... entomologist Greg Johnson. , Urging Montanans to protect themselves with ... sure to emerge when temperatures reach the 70s and 80s. ... as they were in 2003 and 2007, but Montanans should ...
... brain, study reports , , WEDNESDAY, June 11 (HealthDay ... risk of experiencing a stroke in which there is bleeding ... , Researchers, reviewing the medical records of almost 30,000 people ... ran nearly twice the risk of a subarachnoid hemorrhage than ...
... Researchers from the Case Western Reserve University School of ... a novel therapeutic that reduces sterile inflammation within the ... Journal of Leukocyte Biology, Dr. Eric Pearlman and ... compound that when delivered in nano-sized packages reduces corneal ...
... Efficiency in Health Care has assessed recent evidence on allergies. ... symptoms can definitely help many people with allergies. , When ... season has hit its peak. And the number of people ... in get hayfever, and up to half of the population ...
... be quizzed about their children,s sex education in a unique ... taught to deaf pupils. , The University of Manchester,s Audiology ... hearing primary school children for its research on children,s sex ... will make SRE more accessible for deaf children and, at ...
... NEW YORK, June 11 WallSt.net,s 3-Minute Press Show ... Tolentino., Shows air Monday through Friday on: ... interviews with,public company executives on their company and most ... with insight into a company,s most,recent press release, and ...
Cached Medicine News:Health News:Wet or dry, Montana still threatened by West Nile 2Health News:Women, Mexican Americans at Higher Risk for Certain Stroke 2Health News:Latest research on allergies: Specific immunotherapy can help 2Health News:Study aims to improve sex education for deaf pupils 2Health News:Study aims to improve sex education for deaf pupils 3Health News:[video] WallSt.net's '3 Minute Press Show' Features Executive Interviews and Highlights Recent Press for the Following: IUSA, IFUE, FEED, RXEI, GMPM, CRCUF, CVSC, GNMT 2Health News:[video] WallSt.net's '3 Minute Press Show' Features Executive Interviews and Highlights Recent Press for the Following: IUSA, IFUE, FEED, RXEI, GMPM, CRCUF, CVSC, GNMT 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: